Par Pharmaceutical (PRX) volatility collapses on acquisition by TPG for $1.9B

Par Pharmaceutical (NYSE: PRX) is recently up $13.46 to $50.04 on the company being acquired by TPG for $50 per share or $1.9B. August call option implied volatility is at 7, November is at 6; below its 26-week average of 35 according to Track Data, suggesting decreasing price movement.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla (TSLA) call put ratio 1 call to 1.1 puts into quarter results
• Ford Motor (F) call put ratio 2 calls to 1 put into quarter results
• HashiCorp, Inc (HCP) May options active after WSJ report of potential IBM (IBM) deal